Discovery of the novel auxiliary factor for β-lactam resistance BlrA in community-acquired methicillin-resistant Staphylococcus aureus
DOI:
https://doi.org/10.47187/cssn.Vol14.Iss1.212Palabras clave:
auxiliary factors, Staphylococcus aureus, antibiotic resistance, β-lactam antibioticResumen
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most important human pathogens that cause a variety of infections in community and hospital settings. This organism displays high levels of resistance to β-lactam antibiotics and this principally occurs due to the production of β-lactamase and the penicillin binding protein PBP2a encoded by mecA gene. Furthermore, additional mechanisms, such as auxiliary factors, significantly contribute to β-lactam resistance. However, the function of most of these factors is still unknown.
Recently, in our laboratory, the novel auxiliary factor gene blrA was initially identified by transposon mutagenesis in the community-acquired MRSA strain JE2. Next, the transposon mutation was transduced to the community-acquired MRSA strain MW2, resulting in the formation of a transposon mutant for blrA (blrA::ermB), denoted as MW2A. Initially, our results suggested that MW2A is more susceptible to oxacillin than the MW2 wild-type. Then, we performed the Minimum Inhibitory Concentration (MIC) method for the β-lactam antibiotics: oxacillin, cefoxitin, cephradine, ceftazidime, cefaclor and imipenem. MW2A exhibited a two-fold reduction for all tested β-lactam antibiotics compared to the MRSA wild-type strain MW2. Additionally, no phenotypical changes were observed after performing PBP2a latex agglutination test and phage spot assay. Finally, using DeepTMHMM we show that BlrA is likely to act intracellularly, which is typical of auxiliary factors.
In this study, we show that BlrA is clearly involved in β-lactam resistance, but does not affect the expression of the gene mecA or the structure of the wall teichoic acids. Furthermore, we propose that that BlrA acts as an auxiliary factor and is activated in response to antimicrobial stress.
Descargas
Citas
Sakr A, Brégeon F, Mège JL, Rolain JM, Blin O. Staphylococcus aureus Nasal Colonization: An Update on Mechanisms, Epidemiology, Risk Factors, and Subsequent Infections. Front Microbiol. 2018;9:2419.
Zhao N, Cheng D, Jian Y, Liu Y, Liu J, Huang Q, et al. Molecular characteristics of Staphylococcus aureus isolates colonizing human nares and skin. Medicine in Microecology. 2021;7:100031.
Ondusko DS, Nolt D. Staphylococcus aureus. Pediatr Rev. 2018;39(6):287-98.
Cong Y, Yang S, Rao X. Vancomycin resistant Staphylococcus aureus infections: A review of case updating and clinical features. J Adv Res. 2020;21:169-76.
Vermassen A, Leroy S, Talon R, Provot C, Popowska M, Desvaux M. Cell Wall Hydrolases in Bacteria: Insight on the Diversity of Cell Wall Amidases, Glycosidases and Peptidases Toward Peptidoglycan. Frontiers in Microbiology. 2019;10.
Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339(8):520-32.
De Rosa M, Verdino A, Soriente A, Marabotti A. The Odd Couple(s): An Overview of Beta-Lactam Antibiotics Bearing More Than One Pharmacophoric Group. International Journal of Molecular Sciences. 2021;22(2):617.
Zapun A, Contreras-Martel C, Vernet T. Penicillin-binding proteins and β-lactam resistance. FEMS Microbiology Reviews. 2008;32(2):361-85.
Fisher JF, Mobashery S. β-Lactam Resistance Mechanisms: Gram-Positive Bacteria and Mycobacterium tuberculosis. Cold Spring Harb Perspect Med. 2016;6(5).
Panchal VV, Griffiths C, Mosaei H, Bilyk B, Sutton JAF, Carnell OT, et al. Evolving MRSA: High-level β-lactam resistance in Staphylococcus aureus is associated with RNA Polymerase alterations and fine tuning of gene expression. PLoS Pathog. 2020;16(7):e1008672.
Lee AS, de Lencastre H, Garau J, Kluytmans J, Malhotra-Kumar S, Peschel A, et al. Methicillin-resistant Staphylococcus aureus. Nature Reviews Disease Primers. 2018;4(1):18033.
Dittmann K, Schmidt T, Müller G, Cuny C, Holtfreter S, Troitzsch D, et al. Susceptibility of livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) to chlorhexidine digluconate, octenidine dihydrochloride, polyhexanide, PVP-iodine and triclosan in comparison to hospital-acquired MRSA (HA-MRSA) and community-aquired MRSA (CA-MRSA): a standardized comparison. Antimicrob Resist Infect Control. 2019;8:122.
Park MK, Nam DW, Byun JY, Hong SM, Bae CH, Lee HY, et al. Differences in Antibiotic Resistance of MRSA Infections in Patients with Various Types of Otitis Media. J Int Adv Otol. 2018;14(3):459-63.
Arêde P, Ministro J, Oliveira DC. Redefining the role of the β-lactamase locus in methicillin-resistant Staphylococcus aureus: β-lactamase regulators disrupt the MecI-mediated strong repression on mecA and optimize the phenotypic expression of resistance in strains with constitutive mecA expression. Antimicrob Agents Chemother. 2013;57(7):3037-45.
Chen FJ, Wang CH, Chen CY, Hsu YC, Wang KT. Role of the mecA gene in oxacillin resistance in a Staphylococcus aureus clinical strain with a pvl-positive ST59 genetic background. Antimicrob Agents Chemother. 2014;58(2):1047-54.
Fergestad ME, Stamsås GA, Morales Angeles D, Salehian Z, Wasteson Y, Kjos M. Penicillin-binding protein PBP2a provides variable levels of protection toward different β-lactams in Staphylococcus aureus RN4220. MicrobiologyOpen. 2020;9(8):e1057.
Uehara Y. Current Status of Staphylococcal Cassette Chromosome mec (SCCmec). Antibiotics. 2022;11(1):86.
Mikkelsen K, Sirisarn W, Alharbi O, Alharbi M, Liu H, Nøhr-Meldgaard K, et al. The Novel Membrane-Associated Auxiliary Factors AuxA and AuxB Modulate β-lactam Resistance in MRSA by stabilizing Lipoteichoic Acids. International Journal of Antimicrobial Agents. 2021;57(3):106283.
Fey PD, Endres JL, Yajjala VK, Widhelm TJ, Boissy RJ, Bose JL, et al. A genetic resource for rapid and comprehensive phenotype screening of nonessential Staphylococcus aureus genes. mBio. 2013;4(1):e00537-12.
Lade H, Kim JS. Bacterial Targets of Antibiotics in Methicillin-Resistant Staphylococcus aureus. Antibiotics (Basel). 2021;10(4).
Xia G, Wolz C. Phages of Staphylococcus aureus and their impact on host evolution. Infect Genet Evol. 2014;21:593-601.
Hallgren J, Tsirigos KD, Pedersen MD, Almagro Armenteros JJ, Marcatili P, Nielsen H, et al. DeepTMHMM predicts alpha and beta transmembrane proteins using deep neural networks. bioRxiv. 2022:2022.04.08.487609.
Avison MB, Niumsup P, Nurmahomed K, Walsh TR, Bennett PM. Role of the ‘cre/blr-tag’ DNA sequence in regulation of gene expression by the Aeromonas hydrophila β-lactamase regulator, BlrA. Journal of Antimicrobial Chemotherapy. 2004;53(2):197-202.
Jousselin A, Manzano C, Biette A, Reed P, Pinho MG, Rosato AE, et al. The Staphylococcus aureus Chaperone PrsA Is a New Auxiliary Factor of Oxacillin Resistance Affecting Penicillin-Binding Protein 2A. Antimicrob Agents Chemother. 2015;60(3):1656-66.
Miragaia M. Factors Contributing to the Evolution of mecA-Mediated β-lactam Resistance in Staphylococci: Update and New Insights From Whole Genome Sequencing (WGS). Front Microbiol. 2018;9:2723.
Bhagirath AY, Li Y, Patidar R, Yerex K, Ma X, Kumar A, et al. Two Component Regulatory Systems and Antibiotic Resistance in Gram-Negative Pathogens. Int J Mol Sci. 2019;20(7).
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629-55.
Łusiak-Szelachowska M, Międzybrodzki R, Drulis-Kawa Z, Cater K, Knežević P, Winogradow C, et al. Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far. Journal of Biomedical Science. 2022;29(1):23.
Angst DC, Tepekule B, Sun L, Bogos B, Bonhoeffer S. Comparing treatment strategies to reduce antibiotic resistance in an in vitro epidemiological setting. Proc Natl Acad Sci U S A. 2021;118(13).
Slavetinsky CJ, Hauser JN, Gekeler C, Slavetinsky J, Geyer A, Kraus A, et al. Sensitizing Staphylococcus aureus to antibacterial agents by decoding and blocking the lipid flippase MprF. Elife. 2022;11.